BETA BIONICS INC (BBNX) Forecast, Price Target & Analyst Ratings

NASDAQ:BBNXUS08659B1026

Current stock price

8.86 USD
-0.77 (-8%)
At close:
9.03 USD
+0.17 (+1.92%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BETA BIONICS INC (BBNX).

Forecast Snapshot

Consensus Price Target

Price Target
$23.89
+ 169.58% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 21, 2026
Period
Q1 / 2026
EPS Estimate
-$0.50
Revenue Estimate
27.504M

ChartMill Buy Consensus

Rating
82.22%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$23.89
Upside
+ 169.58%
From current price of $8.86 to mean target of $23.89, Based on 18 analyst forecasts
Low
$14.14
Median
$23.97
High
$33.60

Price Target Revisions

1 Month
0.23%
3 Months
-26.36%

Price Target Summary

18 Wall Street analysts provided a forecast for the next 12 months for BBNX. The average price target is 23.89 USD. This implies a price increase of 169.58% is expected in the next year compared to the current price of 8.86.
The average price target has been revised downward by 26.36% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

BBNX Current Analyst RatingBBNX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

BBNX Historical Analyst RatingsBBNX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
82.22%
BBNX was analyzed by 18 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about BBNX.
In the previous month the buy percentage consensus was at a similar level.
BBNX was analyzed by 18 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-09Goldman SachsMaintains Buy -> Buy
2026-02-18StifelMaintains Buy -> Buy
2026-02-18BairdMaintains Neutral -> Neutral
2026-02-04StifelMaintains Buy -> Buy
2026-02-02Truist SecuritiesMaintains Buy -> Buy
2026-01-27TD CowenInitiate Hold
2026-01-09Lake StreetMaintains Buy -> Buy
2026-01-05B of A SecuritiesMaintains Buy -> Buy
2025-12-18Truist SecuritiesMaintains Buy -> Buy
2025-10-29StifelReiterate Buy -> Buy
2025-10-29Truist SecuritiesReiterate Buy -> Buy
2025-10-29Goldman SachsMaintains Buy -> Buy
2025-10-29Piper SandlerReiterate Overweight -> Overweight
2025-10-21StifelReiterate Buy
2025-10-01Goldman SachsUpgrade Neutral -> Buy
2025-09-22Truist SecuritiesMaintains Buy -> Buy
2025-07-30Truist SecuritiesMaintains Buy -> Buy
2025-07-30BairdMaintains Neutral -> Neutral
2025-06-16Truist SecuritiesInitiate Buy
2025-05-30Wolfe ResearchInitiate Outperform
2025-05-30Goldman SachsInitiate Neutral
2025-02-24Leerink PartnersInitiate Outperform
2025-02-24Lake StreetInitiate Buy
2025-02-24StifelInitiate Buy
2025-02-24Piper SandlerInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 21, 2026
Period
Q1 / 2026
EPS Estimate
-$0.50
Revenue Estimate
27.504M
Revenue Q2Q
55.93%
EPS Q2Q
46.41%
Number of Analysts
13

Next Earnings Revisions

Revenue (1 Month)
0.22%
Revenue (3 Months)
-2.14%
EPS (1 Month)
-3.04%
EPS (3 Months)
-3.35%

Next Earnings Summary

BBNX is expected to report earnings on 4/21/2026. The consensus EPS estimate for the next earnings is -0.5 USD and the consensus revenue estimate is 27.50M USD.
The next earnings revenue estimate has been revised downward by 2.14% in the past 3 months.

Full Analyst Estimates 2026 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
BBNX revenue by date.BBNX revenue by date.
11.995M
6,601.12%
65.124M
442.93%
100.251M
53.94%
135.24M
34.90%
182.07M
34.63%
255.3M
40.22%
357.05M
39.86%
460.07M
28.85%
517.14M
12.40%
634.44M
22.68%
EBITDA
YoY % growth
BBNX ebitda by date.BBNX ebitda by date.
-34.624M
46.32%
-44.1M
-27.37%
-70.108M
-58.98%
-71.555M
-2.06%
-69.372M
3.05%
-42.088M
39.33%
-33.15M
21.24%
-10.608M
68.00%
N/AN/A
EBIT
YoY % growth
BBNX ebit by date.BBNX ebit by date.
-35.85M
45.55%
-45.251M
-26.22%
-71.681M
-58.41%
-98.423M
-37.31%
-99.754M
-1.35%
-81.245M
18.56%
-60.18M
25.93%
-25.5M
57.63%
52.02M
304.00%
68.34M
31.37%
Operating Margin
BBNX operating margin by date.BBNX operating margin by date.
-298.87%-69.48%-71.50%-72.78%-54.79%-31.82%-16.85%-5.54%10.06%10.77%
EPS
YoY % growth
BBNX eps by date.BBNX eps by date.
N/AN/A-1.94
8.78%
-1.95
-0.29%
-1.95
-0.44%
-1.33
31.77%
-1.93
-44.59%
-1.51
21.69%
N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth
-0.50
46.41%
-0.51
-29.67%
-0.48
-44.13%
-0.47
-63.06%
-0.48
3.53%
-0.47
6.55%
-0.47
1.57%
-0.48
-2.24%
-0.18
61.81%
-0.19
58.99%
-0.15
67.32%
-0.12
74.68%
Revenue
Q2Q % growth
27.504M
55.93%
32.144M
38.33%
35.526M
30.36%
39.983M
24.48%
38.284M
39.19%
42.827M
33.23%
47.582M
33.94%
53.834M
34.64%
57.13M
49.23%
61.241M
43.00%
66.341M
39.42%
72.593M
34.85%
EBITDA
Q2Q % growth
-20.166M
-9.96%
-19.153M
0.36%
-16.672M
-4.15%
-15.73M
-8.10%
-15.546M
22.91%
-15.601M
18.55%
-16.242M
2.58%
-17.376M
-10.47%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-25.396M
-36.23%
-25.537M
-28.51%
-24.08M
-41.29%
-23.684M
-46.89%
-23.358M
8.03%
-24.089M
5.67%
-23.381M
2.90%
-24.027M
-1.45%
-11.159M
52.23%
-11.873M
50.71%
-9.578M
59.04%
-7.844M
67.35%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

BBNX Yearly Revenue VS EstimatesBBNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
BBNX Yearly EPS VS EstimatesBBNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
9.49%
EPS Next 5 Year
4.09%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
36.48%
Revenue Next 5 Year
35.58%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
13.38%
EBIT Next 5 Year
13.25%

BETA BIONICS INC / BBNX Forecast FAQ

What is the price target for BBNX stock?

18 analysts have analysed BBNX and the average price target is 23.89 USD. This implies a price increase of 169.58% is expected in the next year compared to the current price of 8.86.

When does BETA BIONICS INC (BBNX) report earnings?

BETA BIONICS INC (BBNX) will report earnings on 2026-04-21.

What are the consensus estimates for BETA BIONICS INC (BBNX) next earnings?

The consensus EPS estimate for the next earnings of BETA BIONICS INC (BBNX) is -0.5 USD and the consensus revenue estimate is 27.50M USD.

What is the consensus rating for BETA BIONICS INC (BBNX) stock?

The consensus rating for BETA BIONICS INC (BBNX) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.